weight loss, food and drug administration

We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...
Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...
Each brand has its own formula for helping users achieve their weight loss goals. Their methods include remote healthcare ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Injectable GLP-1 agonists help people struggling to lose weight. Patients are finding the drug also helps reduce recurring ...
That is half of the NHS entire drugs budget. The NHS has restricted Mounjaro to just 220,000 people over the next three years. Many people who stop taking weight loss injections put the ...
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...